Comparative Study of Hepatitis B Pts:The BE-LOW Study
ID Number 07-0557
Principal Investigator(s)Douglas Dieterich
Department(s) or Division(s)
Liver Diseases
Description
The purpose of this study is find out how safe and effective the combination of entecavir (a nucleoside analog) plus tenofovir (a nucleotide analog) is compared to entecavir alone for the treatment of hepatitis B infection.
Contact Information
Douglas Dieterich, MD
douglas.dieterich@mountsinai.org
Recruiting Patients: No